{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:47Z","timestamp":1792114247190,"version":"4.4.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background and aims:<\/jats:bold> As a major cause of liver disease worldwide, non-alcoholic fatty liver disease (NAFLD) comprises non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Due to the high prevalence and poor prognosis of NASH, it is critical to understand its mechanisms. However, the etiology and mechanisms remain largely unknown. In addition, the gold standard for the diagnosis of NASH is liver biopsy, which is an invasive procedure. Therefore, there is a pressing need to develop noninvasive tests for NASH diagnosis. The goal of the study is to discover key genes involved in NASH development and investigate their value as noninvasive biomarkers.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The Gene Expression Omnibus (GEO) database was used to obtain two datasets encompassing NASH patients and healthy controls. We used weighted gene co-expression network analysis (WGCNA) and differential expression analysis in order to investigate the association between gene sets and clinical features, as well as to discover co-expression modules. A protein-protein interaction (PPI) network was created to extract hub genes. The results were validated using another publicly available dataset and mice treated with a high-fat diet (HFD) and carbon tetrachloride (CCl4).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 24 differentially co-expressed genes were selected by WGCNA and differential expression analysis. KEGG analysis indicated most of them were enriched in the focal adhesion pathway. GO analysis showed these genes were mainly enriched in circadian rhythm, aging, angiogenesis and response to drug (biological process), endoplasmic reticulum lumen (cellular component), and protein binding (molecular function). As a result, eight genes (JUN, SERPINE1, GINS2, TYMS, HMMR, IGFBP2, BIRC3, TNFRSF12A) were identified as hub genes. Finally, three genes were found significantly changed in both the validation dataset and the mouse model.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our research discovered genes that have the potential to mediate the process of NASH and might be useful diagnostic biomarkers for the disorder.<\/jats:p>","DOI":"10.3389\/fgene.2022.872518","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T05:42:00Z","timestamp":1650951720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qingnan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1073\/pnas.1103623108","article-title":"Identification of a De Novo Thymidylate Biosynthesis Pathway in Mammalian Mitochondria","volume":"108","author":"Anderson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"key":"B2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11739-009-0240-9","article-title":"Relationships of PAI-1 Levels to central Obesity and Liver Steatosis in a Sample of Adult Male Population in Southern Italy","volume":"4","author":"Barbato","year":"2009","journal-title":"Intern. Emerg. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-62703-748-8_4","article-title":"Introduction to Bioinformatics","volume":"1107","author":"Can","year":"2014","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a Package for the Generation of Highly-Customizable Venn and Euler Diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC bioinformatics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1530\/ec-21-0353","article-title":"IGFBP-2 as a Biomarker in NAFLD Improves Hepatic Steatosis: an Integrated Bioinformatics and Experimental Study","volume":"10","author":"Chen","year":"2021","journal-title":"Endocr. connections"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: Identifying Hub Objects and Sub-networks from Complex Interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/hep4.1396","article-title":"Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance","volume":"3","author":"Dali-Youcef","year":"2019","journal-title":"Hepatol. Commun."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114144","article-title":"Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men","volume":"21","author":"Fahlbusch","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in Tissue Fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/hep4.1259","article-title":"Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice","volume":"2","author":"Henkel","year":"2018","journal-title":"Hepatol. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of Ggplot2 to Pharmacometric Graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7561645","DOI":"10.1155\/2021\/7561645","article-title":"Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis","volume":"2021","author":"Jiang","year":"2021","journal-title":"Biomed. Research International"},{"key":"B17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1440-1681.12102","article-title":"A High-Fat Diet and Multiple Administration of Carbon Tetrachloride Induces Liver Injury and Pathological Features Associated with Non-alcoholic Steatohepatitis in Mice","volume":"40","author":"Kubota","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R Package for Weighted Correlation Network Analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89746","DOI":"10.18632\/oncotarget.21120","article-title":"TM5441, a Plasminogen Activator Inhibitor-1 Inhibitor, Protects against High Fat Diet-Induced Non-alcoholic Fatty Liver Disease","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cld.2017.08.014","article-title":"Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma","volume":"22","author":"Massoud","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, Present and Future Perspectives in Nonalcoholic Fatty Liver Disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2164-10-405","article-title":"Weighted Gene Co-expression Network Analysis of the Peripheral Blood from Amyotrophic Lateral Sclerosis Patients","volume":"10","author":"Saris","year":"2009","journal-title":"BMC genomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-3652-6_3","article-title":"Introduction to the Gene Expression Analysis","volume":"1434","author":"Segundo-Val","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating Levels and Hepatic Expression of Molecular Mediators of Atherosclerosis in Nonalcoholic Fatty Liver Disease","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","article-title":"Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease","volume":"106","author":"Stanley","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of Liver Biopsy and Non-invasive Diagnostic Tests for the Diagnosis of Nonalcoholic Fatty Liver Disease\/nonalcoholic Steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"920676","DOI":"10.1155\/2014\/920676","article-title":"Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with normal or Slightly Increased Liver Enzymes","volume":"2014","author":"Tarantino","year":"2014","journal-title":"Oxidative Med. Cell. longevity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic Factors in Histologically Proven Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/mmr.2019","article-title":"Identification of Hub Genes and Key Pathways of Dietary Advanced Glycation End Products-Induced Non-alcoholic Fatty Liver Disease by Bioinformatics Analysis and Animal Experiments","volume":"21","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/hep.23645","article-title":"Macroautophagy and Chaperone-Mediated Autophagy Are Required for Hepatocyte Resistance to Oxidant Stress","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"772487","DOI":"10.3389\/fgene.2021.772487","article-title":"Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1038\/ncomms4231","article-title":"Gene Co-expression Network Analysis Reveals Common System-Level Properties of Prognostic Genes across Cancer Types","volume":"5","author":"Yang","year":"2014","journal-title":"Nat. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1025857","DOI":"10.1155\/2020\/1025857","article-title":"Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes","volume":"2020","author":"Ye","year":"2020","journal-title":"J. Immunol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic Fatty Liver Disease - A Global Public Health Perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5633211","DOI":"10.1155\/2021\/5633211","article-title":"WGCNA-based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease","volume":"2021","author":"Zeng","year":"2021","journal-title":"Biomed. Research International"},{"key":"B38","doi-asserted-by":"publisher","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","article-title":"A General Framework for Weighted Gene Co-expression Network Analysis","volume":"4","author":"Zhang","year":"2005","journal-title":"Stat. Appl. Genet. Mol. Biol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.872518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T05:42:03Z","timestamp":1650951723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.872518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":38,"alternative-id":["10.3389\/fgene.2022.872518"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.872518","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"872518"}}